OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Cardiology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	277
A Woman With Recurrent Torsade de Pointes	244
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	235
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	196
Primary Prevention Management of Elevated Lipoprotein(a)	186
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	178
Error in Table 1	168
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	163
JAMA Cardiology	158
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	157
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	149
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	147
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	137
Chest Pain in a Middle-Aged Man	137
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	135
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	129
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	128
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	128
Genome-Wide Association Study of Accessory Atrioventricular Pathways	111
JAMA Cardiology	111
USPSTF Report on Aspirin for Primary Prevention	106
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	101
Accountable Care Organization Participation and Cardiovascular Care Quality	101
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	98
Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	98

Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	96
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	93
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	92
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	91
JAMA Cardiology	91
Assessing Performance of Machine Learning—Reply	90
Supraventricular Tachycardia Following Mitral Valve Surgery	89
JAMA Cardiology	88
What Is Your Secret to Health?	87
Hypertriglyceridemia in the MESA Study—Reply	87
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	87
Innovation in Event Adjudication—Human vs Machine	86
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	85
Peak Oxygen Uptake vs Ventilatory Efficiency	83
Contribution of Clinical Trial Event Data by Data Source	82
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	81
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	81
User Trust in Artificial Intelligence–Guided Lung Ultrasound	80
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	79
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	79
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	77
Left Atrial Appendage Closure After Thrombus Aspiration—Reply	74
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	73
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	73
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	72
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	69
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	67
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	65
Change to Open Access Status	65
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	64
Corrected to Open Access Status	64
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	63
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	62
Error in Figure	61
Young Man With Coarctation of the Aorta	61
PCSK9 in Familial Hypercholesterolemia and Beyond	60
JAMA Cardiology	60
Optimizing Cascade Testing to Advance Health Equity in Cardiac Amyloidosis	60
Exercise Capacity in Young Adults Born Small for Gestational Age	59
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	58
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation	57
An Expanded Heart Failure Indication for Sacubitril/Valsartan	57
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	56
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	55
JAMA Cardiology	55
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	54
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	54
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	53
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	53
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	52

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	51
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	51
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US	51
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	51
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events	50
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	50
A Woman With Syncope and Frequent Premature Ventricular Contractions	49
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	49
To Occlude or Not to Occlude the Left Atrial Appendage in Women	49
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	49
JAMA Cardiology	49
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	48
Error in Abstract and Results	48
Passing the Stethoscope	48
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	48
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	47
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	47
Troponins and Pregnancy—Reply	47
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	47
Error in Figure 1	47
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	46
When Is a Placebo Not a Placebo	46
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	45
Preserving and Promoting Clinical Trial Representativeness	45
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	45
Clonal Hematopoiesis—Fuel to Inflame the Heart	45
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	44
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	43
Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes	43
The 3.5-Inch View—On Perspective and the Medical Profession	43
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	43
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	43
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	42
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	42
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	41
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	41
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	40
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	39
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	39
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	39
JAMA Cardiology	38
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	38
Incidental Complication From a Left Atrial Appendage Device	38
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	38
In Honor of the Pig	38
Early Mortality in Type A Acute Aortic Dissection	38
My Grandfather’s Blueprint	37
An Elderly Woman With Ventricular Tachycardia	37
JAMA Cardiology	37
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	37
Errors in Key Points, Abstract, Results, and Figures	37
Corrected to Open Access Status	36
Errors in Author Affiliations and Open Access Updated	36
Error in Abstract	36
JAMA Cardiology	36
Reflections of an Editorial Fellow—A Window Into Medical Publishing	35
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	35
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	35
Error in Table	35
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	34
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	34
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	34
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	34
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	34
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	34
The Limitations and Risks Associated With Semaglutide Treatment—Reply	34
Preventing Declines in Cardiovascular Health From Childhood	34
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension—Reply	33
The Last Mile in Prevention—Can Coronary CT Angiography Help?	33
Error in Results	33
Finerenone in Heart Failure—Reply	32
PREVENT Risk Age Equations and Population Distribution in US Adults	32
JAMA Cardiology	32
One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation	32
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	32
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	32
Bizarre Wide-Complex Tachycardia in a Man in His 60s With Severe Chest Pain	32
Medicine, Writing, and the Limits of Language	31
Moving Beyond Conventional Guesstimation to Guide PCI	31
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk	31

A Young Woman With Dyspnea During Cardiac Catheterization	31
A Man in His 60s With Severe Heart Failure and Incessant Ventricular Arrhythmias	31
JAMA Cardiology	30
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	30
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	30
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	30
Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	30
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	29
Comment on Aspirin Avoidance in Patients With LVADs	29
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	29
Updated USPSTF Guidelines for Screening for Atrial Fibrillation	29
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	29
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	29
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	28
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	28
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes	28
Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018	28
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	27
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	27
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	27
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	27
JAMA Cardiology	27
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	26
A Teenager With Palpitations	26
JAMA Cardiology	25
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	25
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	24
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	24
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	24
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	24
The Fine Art and Science of Translating Trials Results Into Clinical Practice	24
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	24
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	24
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	24
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	23
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related Cardiomyopathies	23
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	23
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	23
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	23
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	23
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	23
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	23
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	23
Patient Enrollment for Cardiovascular Clinical Trials in the United States	23
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	23
Transient Monocular Blindness in a Man in His 30s	22
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	22
Private Equity and Cardiovascular Health Care	22
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery	22
Authenticity—An Uphill Battle for a Black Woman in Cardiology	22
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	22
Error in Abstract and Methods	22
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US	21
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	21
Variants at the Interleukin 1 Gene Locus and Pericarditis	21
Inquiry Regarding Body Temperature Data in HuMAIN-HFpEF Trial	21
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	21
Blood Pressure Control After SPRINT—Back to Reality	21
JAMA Cardiology	21
Salt Substitution and Recurrent Stroke and Death—Reply	21
Women’s Representation in Interventional Cardiology	21
High-Risk Areas—The Trees in the Forest—Reply	21
Heart Failure and Nonoptimal Temperatures	20
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	20
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	20
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction	20
Discontinuation of Semaglutide Among Older Adults With Diabetes in the US and Japan	20
Hospitalization Rates Alone Do Not Define Health Systems—Reply	20
Genetic Testing in Early-Onset Atrial Fibrillation	19
Educational Attainment and Lifetime Risk of Cardiovascular Disease	19
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	19
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis	19
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	19
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	19
Long-term Survival After Out-of-Hospital Cardiac Arrest	19
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	19
Errors in Abstract	18
Omitted Affiliation	18
Error in the First Paragraph	18
Reducing the Risks of Nuclear War—The Role of Health Professionals	18
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	18
Heart Failure—Together We Go Farther—Reply	18
What’s VAT All About—The Clue Is in the Genetics	18
JAMA Cardiology Peer Reviewers in 2021	18
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	18
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events	18
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	18
Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region	18
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	18
Can Noncalcified Plaques Contribute to Future Coronary Events?	17
Management of Postpartum Left Main Spontaneous Coronary Artery Dissection	17
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy	16
Error in Figure 1	16